SCHEMBL14547722

SCHEMBL14547722

FC(F)(F)CNc1nc(Nc2ccc(-c3cnco3)cc2)nc2[nH]ccc12

nearest known ligand 0.60

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ LRRK2 Q5S007 3/20 0.60
▸ SYK P43405 8/20 0.55
▸ JAK2 O60674 5/20 0.55
▸ PTK2 Q05397 5/20 0.55
▸ PAK4 O96013 4/20 0.55
▸ DAPK3 O43293 3/20 0.55
▸ RET P07949 3/20 0.55
▸ LTK P29376 3/20 0.55
▸ MAPK8 P45983 3/20 0.55
▸ CLK2 P49760 3/20 0.55
▸ RPS6KA3 P51812 3/20 0.55
▸ MAP4K2 Q12851 3/20 0.55
▸ ROCK1 Q13464 3/20 0.55
▸ NTRK2 Q16620 3/20 0.55
▸ ALK Q9UM73 3/20 0.55
▸ ABL1 P00519 2/20 0.55
▸ LCK P06239 2/20 0.55
▸ FYN P06241 2/20 0.55
▸ GRK5 P34947 2/20 0.55
▸ CSNK1A1 P48729 2/20 0.55

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL14547958 0.81 LRRK2 (0.72) LRRK2SYKJAK2PTK2PAK4
SCHEMBL14547849 0.81 LRRK2 (0.69) LRRK2SYKJAK2PTK2PAK4
SCHEMBL14547781 0.80 LRRK2 (0.58) LRRK2SYKJAK2PTK2PAK4
SCHEMBL14547935 0.80 LRRK2 (0.74) LRRK2SYKJAK2PTK2PAK4
SCHEMBL14547919 0.79 LRRK2 (0.70) LRRK2SYKJAK2PTK2PAK4
SCHEMBL14547850 0.78 LRRK2 (0.62) LRRK2SYKJAK2PTK2PAK4
SCHEMBL14547787 0.77 LRRK2 (0.59) LRRK2SYKJAK2PTK2PAK4
SCHEMBL14547858 0.77 LRRK2 (0.59) LRRK2SYKJAK2PTK2PAK4
SCHEMBL14547965 0.77 LRRK2 (0.67) LRRK2SYKJAK2PTK2PAK4
SCHEMBL14547949 0.76 LRRK2 (0.60) LRRK2SYKJAK2PTK2PAK4

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2007042299-A1 PYRROLOPYRIMIDINE DERIVATIVES AS SYK INHIBITORS GLAXO GROUP LIMITED (GB) 2007-04-19 — — WO disclosed
Send feedback